Robyn L Peters is a global life sciences and healthcare executive, and independent board director with over 30 years of experience leading successful large-scale commercialization efforts and critical turnarounds across biopharmaceutical and provider areas, including Pfizer, Inc., Walgreens Company, and Biogen. Robyn's commercial expertise spans biotech, retail and specialty pharmacy, payer, hospital & integrated health systems, and healthcare services — managing from $3B to $50B P&L oversight. She has experience in enterprise risk management, internal audits & SOX requirements, talent acquisition and compensation, mergers and acquisitions, and corporate restructuring.

Robyn has advised CEOs, the C-suite, and the Board of Directors at Biogen, Walgreens, and Pfizer and has extensive experience providing board-ready materials and information for investor meetings, quarterly earnings, annual reports, and risk, audit, and financial committees. She continues to consult and advise CEOs and boards of directors in growth-stage healthcare companies, focusing on information technology, tech-enabled services, and services sectors in her role as Operating Partner, Valspring Capital.

Boards: Kalderos, Sempre Health